Gilead Sciences

The FDA granted the drug accelerated approval for its use in metastatic triple-negative breast cancer (mTNBC) patients who had…

The drug will be produced at its sterile drug product manufacturing plant in Hyderabad which is WHO GMP certified

The deal, which will expand Gilead’s oncology portfolio, might get announced tomorrow if not sooner, inform reports

Jounce will lead the development of JTX-1811 through IND clearance, and thereafter, Gilead will have the sole right to develop…

The 600-patient analysis found that moderately-ill patients treated with Remdesivir for up to five days had significantly higher…

The US drug regulator has issued a complete response letter requesting data from the MANTA and MANTA-RAy studies and expressing…

To boost the drug’s availability globally, Gilead has signed multiple manufacturing and supply deals, including with Pfizer and…

Pfizer will provide contract manufacturing services through its McPherson, Kansas plant

The company, which had initially released the data from the trial in April, said the finding requires confirmation in clinical…

The company said the trial will test the drug particularly in those cases where the disease has not progressed to require…